Apr 11, 2014; Chicago, IL, USA; Chicago White Sox starting pitcher Chris Sale (49) throws a pitch against the Cleveland Indians during the first inning at U.S Cellular Field. Mandatory Credit: Mike DiNovo-USA TODAY Sports
One rehab start up, one rehab start down for Chicago White Sox ace Chris Sale, as he had a successful outing for the Charlotte Knights, Friday against the Durham Bulls.
Here is what MLB.com wrote about the outing:
"“His 68-pitch performance included 43 strikes. He struck out seven different Bulls … Sale struck out 11 batters in four innings in the first game of a doubleheader.”"
How great is it to see Sale perform to this level in his first of hopefully only two rehab outings for the left-hander?
Sale even spoke about his performance in the MLB.com article:
"“I feel ready [to return to the big leagues], but that decision isn’t up to me.”"
Maybe he performed well enough to not have to have a second rehab start. Now let’s hope Sale can recover well from the four innings he pitched. Who knows, maybe the folks in charge will be willing to just put him in the majors for his next scheduled start, which would be most likely against the Kansas City Royals or possibly against the New York Yankees.
More from White Sox News
- The Chicago White Sox might have had a season ending loss
- The Chicago White Sox are expecting Tim Anderson back soon
- Miguel Cairo’s words spark life into the Chicago White Sox
- Dylan Cease should be the favorite for the AL Cy Young Award
- Ozzie Guillen speaks the whole truth about Tony La Russa
If he has to have another rehab start, his return to the majors could be May 27-28 against the Cleveland Indians at U.S. Cellular Field.
This season, with the White Sox, Sale is 3-0 with an ERA of 2.30.
Now we just have to wait and see what the front office and the doctors decide what Sale will do next.
Subscribe to the Southside Showdown free daily newsletter from FanSided by clicking here or add the FanSided mobile app by clicking here. Please follow Southside Showdown on Twitter and like us on Facebook.